Latest Regulatory Approval News

EVE Health Group has executed a binding agreement to acquire Australian biotech Nextract, targeting rapid-onset treatments in the $16 billion global erectile dysfunction and dysmenorrhea markets. The acquisition, supported by a $1.5 million capital raise and share consolidation, marks a strategic shift into regulated pharmaceutical channels.

Avenira Limited is advancing its Wonarah Phosphate Project with site mobilisation planned for mid-2025, backed by a $7.567 million capital injection from major shareholder Sichuan Hebang Technology. Operational milestones and regulatory approvals are progressing, positioning the company for first ore shipment in Q4.

Highfield Resources has made significant progress on its strategic transaction with Yankuang Energy and Beijing Energy, securing key regulatory approvals and restructuring its financing amid disciplined cost management.

Asra Minerals has completed a comprehensive target generation exercise at its Leonora Gold Projects, identifying 26 priority drill-ready gold targets and securing regulatory approval to commence drilling in Q2 2025. The company also strengthened its balance sheet with a $3 million placement and asset sale proceeds.

Nexus Minerals reports breakthrough regional exploration success at its Wallbrook Gold Project with two new significant gold discoveries and expanded mineralisation footprints, while progressing mine studies and permit applications.

Imagion Biosystems has progressed its MagSense HER2 breast cancer imaging agent towards a pivotal Investigational New Drug application with the FDA, backed by a solid funding runway exceeding 13 quarters.

Cokal Limited advanced its Indonesian metallurgical coal projects in Q1 2025 with key financing secured by joint venture partner PT Petrindo, completion of critical infrastructure, and a strategic US$7 million prepayment facility. These developments underpin Cokal’s strategy to ramp up production while reducing costs amid challenging market conditions.

Sabre Resources advances exploration across uranium, nickel, lithium, and gold projects while securing a $1.6 million sale of its Ninghan Gold Project to Capricorn Metals.

Trinex Minerals has identified promising lithium soil geochemistry trends at its Dudley Lithium Project and secured approvals for drilling, while completing a key share issuance for its Canadian East Yellowknife Lithium Project.

Echelon Resources delivered a robust March 2025 quarter with production volumes up 5% and development wells at Mereenie surpassing expectations. The company also moved to acquire full operatorship of EP145 in the Amadeus Basin, signaling strategic growth despite exploration setbacks.

Lakes Blue Energy is progressing regulatory approvals and has locked in a drilling rig for its Wombat-5 gas well, while reporting a $1.48 million operating cash outflow and maintaining $3.55 million in cash at quarter-end.

Dimerix Limited advances its Phase 3 kidney disease trial with FDA acceptance of proteinuria as a primary endpoint and clinches a lucrative licensing agreement in Japan worth up to AU$107 million plus royalties.